Displaying 80 (all) recruiting clinical trials.
-
A Phase III Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Acute Anxiety in Patients with Social Anxiety Disorder for VQW-765
The purpose of the study is to evaluate the effect of an investigational drug called VQW-765 on acute symptoms associated with social anxiety disorder (SAD ... -
A Phase 2a Multicenter Dose Escalation and Dose Optimization Study of SYNC-T Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
This is a Phase 2 study testing a treatment called SYNC-T Therapy SV-102 in adult men with metastatic castration-resistant prostate cancer (mCRPC). SYNC-T Therapy SV-102 ...
-
An Open-label Single-Arm Phase 2 Study to Evaluate Enfortumab Vedotin plus Pembrolizumab for Bladder Preservation in Participants with Muscle-invasive Bladder Cancer
This is a global, open-label, phase 2 study in adult participants with histologically confirmed MIBC (stage cT2–T4aN0M0 or T1-T4aN1M0) who are eligible for RC ... -
PAXIS: A randomized double-blind placebo-controlled dose-finding phase 2 study (Part 1) followed by an open-label period (Part 2) to assess the efficacy and safety of pacritinib in patients with VEXAS syndrome
The purpose of this study is to learn about the safety and effectiveness of a study drug called pacritinib, and to determine what dose of ... -
A Phase 2 multicenter clinical study to evaluate the efficacy and safety of safusidenib erbumine in patients with isocitrate dehydrogenase 1 (IDH1)-mutant glioma
This is a Phase 2 study testing whether the new drug, safusidenib, is safe and effective in patients with glioma, a type of brain tumor ...
-
A Phase 2 Randomized Blinded Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab versus Placebo in Combination with Pembrolizumab Pemetrexed and Carboplatin in First-Line Treatment of Participants with Metastatic Non-Squamous Non-Small Cell Lung Cancer (GDFATHER-NSCLC-01)
This is a Phase 2 study testing a new medicine called Visugromab (also called CTL-002) to see how well it works with standard cancer treatments ...
-
A Phase 2 Multicenter Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants with FGFR3 Altered Low Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer
This study will investigate the safety, tolerability of TYRA-300 and assess different doses of TYRA-300 in participants harboring FGFR3 mutations and/or fusions with intermediate ... -
ELEVATE
The purpose of this research study is to provide evidence on the clinical benefit, effectiveness, and safety of the experimental TI1132 implant and associated totally ... -
A Randomized Double-Blind Placebo-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Generalized Anxiety Disorder
The purpose of this study is to test an investigational drug called RE104 for the treatment of a mental health condition called Generalized Anxiety Disorder ... -
RADIation after no Axillary Nodal Sampling (RADIANS)
This is a single arm, pilot, prospective study to evaluate the safety of partial breast irradiation in women who undergo breast conserving surgery without SLNB ...